New pill could quiet restless legs – early trial underway
NCT ID NCT07453862
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is testing a new calcium channel modulator to see if it can ease symptoms of Restless Legs Syndrome (RLS). About 20 adults with moderate-to-severe RLS will take the drug twice a day for 12 weeks. Researchers will measure changes in symptom severity and watch for side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESTLESS LEG SYNDROME (RLS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Capital Medical University Affiliated Beijing Friendship Hospital
RECRUITINGBeijing, Beijing Municipality, 100050, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Two-Question survey could help doctors catch sleep disorders earlier
- Could a gentle zap to the neck ease restless legs in dialysis patients?
- Spinal zaps could quiet restless legs in Drug-Resistant patients
- Cannabis oil put to the test for restless legs in First-Ever controlled trial
- Could a Light-and-Vibe combo soothe restless legs in diabetes?
- Simple relaxation technique may soothe restless legs in dialysis patients